Artelo Biosciences ARTL
NASDAQ ARTL
$2.18 +0.04 (+1.76%)
As of: Nov 11, 2026 · 3:59 PM EST

Artelo Biosciences (ARTL) Interest Coverage Ratio (2017 - 2026)

Updated

Artelo Biosciences' Interest Coverage Ratio was -26.89 in Q1 2026.

Analysis

Artelo Biosciences (ARTL) Interest Coverage Ratio (2017 - 2026) Analysis & Trends

On a trailing twelve-month basis, Artelo Biosciences' Interest Coverage Ratio was -39.84 through Mar 31, 2026; for FY2025, it was -58.78.

  • In earlier years, Interest Coverage Ratio was -2057.40 in FY2022.
  • The Q1 2026 figure marks the highest quarterly Interest Coverage Ratio since Q2 2017.
  • Per Business Quant data, ARTL's Interest Coverage Ratio in the three quarters before Q1 2026 was -253.27 (Q4 2025), -27.83 (Q3 2025) and -43.75 (Q2 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 28.50
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.20
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 5.68
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 12.87
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Artelo Biosciences 49.32 Mn 32.53 Mn - -417.50
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -417.50
Mar 31, 2026 -26.89
Dec 31, 2025 -253.27
Sep 30, 2025 -27.83
Jun 30, 2025 -43.75
Sep 30, 2022 -478.80
Nov 30, 2019 -2.28
Aug 31, 2017 -652.84
May 31, 2017 -105.54
Feb 28, 2017 -11.81
API Access

Artelo Biosciences Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=ARTL&period=max&api_key=YOUR_API_KEY